KHN Morning Briefing

Summaries of health policy coverage from major news organizations

full issue

Emails Reveal Behind-The-Scenes Drama Of FDA’s Drug Approval Process

Last year, a fierce battle emerged over Sarepta's new muscular dystrophy drug, in which FDA official Janet Woodcock approved the treatment -- overruling the recommendations of a review team and an advisory committee. Newly released emails show what happened next.

In other pharmaceutical news —

The Associated Press: FDA OKs New Drug To Treat All Forms Of Hepatitis C
U.S. regulators have approved the first drug to treat all forms of hepatitis C in as little as eight weeks. The pill combination from AbbVie Inc. was approved Thursday by the Food and Drug Administration for adults without significant cirrhosis, a type of liver disease, and many patients who were not cured by prior treatment. (8/3)

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.